ATXN8OS Intermediate Expansion Acts as a Genetic Modifier in Spinocerebellar Ataxia Type 48 ( SCA48 / STUB1 )
Open Access
- 21 September 2026
- journal article
- research article
- Published by Wiley in Movement Disorders
Abstract
Background: Association between monoallelic STUB1 variant and expanded ATXN8OS alleles was recently reported, suggesting a pathogenic interaction that may influence spinocerebellar ataxia type 48 (SCA48) phenotype. Objectives: We investigated the frequency and clinical impact of ATXN8OS in a large cohort of STUB1 carriers compared to individuals with other ataxias and controls. Methods: Ataxic individuals and controls from the SPATAX/BIOMOV cohorts (Paris Brain Institute) were screened for ATXN8OS and other CAG expansions using polymerase chain reaction (PCR)/repeat‐prime PCR (RP‐PCR) and ExpansionHunter . STUB1 carriers underwent whole‐genome or exome sequencing. Results: Our cohort comprised 12 biallelic STUB1 carriers (SCAR16) and 67 monoallelic STUB1 carriers (SCA48) without other causative variants. ATXN8OS expansions (84–177 CTA/CTG repeats) were identified in seven SCA48 individuals (10.5%) who exhibited earlier onset (median age 28 vs. 47 years, P < 0.001) compared to other SCA48 individuals but with similar clinical presentation. ATXN8OS expansions were also found in two healthy controls older than 50 years (2/286, 0.7%) and in eight index cases with autosomal dominant ataxia (8/400, 2%), including four carrying another molecular diagnosis without any effect on the phenotype. Other intermediate expansions were identified in individuals with SCA48: seven (10.5%) carried intermediate TBP alleles (40–46 CAG/CAA) without any effect on dementia prevalence; four carried intermediate HTT alleles (28–29 CAG); and three carried intermediate ATXN1 expansions (38 CAG). Conclusions: ATXN8OS intermediate expansion acts as a genetic modifier in SCA48 but not in other ataxias. Moreover, expanded intermediate alleles in neurodegenerative disease genes were present in one‐third of SCA48 individuals. These alleles may increase polyglutamine burden, potentially saturating STUB1 E3 ubiquitin ligase activity. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.Keywords
This publication has 44 references indexed in Scilit:
- TBP Repeat Expansion Analysis in Patients Carrying Heterozygous STUB1 VariantsMovement Disorders, 2025
- STUB1 Mutations as Possible Genetic Modifiers in Spinocerebellar Ataxia Type 8Movement Disorders, 2024
- Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxiasThe American Journal of Human Genetics, 2023
- Genotype–Phenotype Correlations for ATX‐TBP (SCA17): MDSGene Systematic ReviewMovement Disorders, 2022
- STRipy: A graphical application for enhanced genotyping of pathogenic short tandem repeats in sequencing dataHuman Mutation, 2022
- Digenic inheritance of STUB1 variants and TBP polyglutamine expansions explains the incomplete penetrance of SCA17 and SCA48Genetics in Medicine, 2022
- Clinical and Genetic Characterization of Autosomal Recessive Spinocerebellar Ataxia Type 16 (SCAR16) in TaiwanThe Cerebellum, 2020
- PSP-Phenotype in SCA8: Case Report and Systemic ReviewThe Cerebellum, 2018
- A Family With Spinocerebellar Ataxia Type 8 Expansion and Vitamin E Deficiency AtaxiaArchives of Neurology, 2002
- Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Italy.Archives of Neurology, 2001